Psychedelic Drugs Market Size, Share, Growth, Trends, Forecast 2022-2030 || Research Report
                     Psychedelic 
Drugs Market 
Research, 2032
By Allied Market Research
Market Statistics
• Market Size in 2022: $0.7 billion
• Projected Value in 2032: $2.6 billion 
• CAGR: 13.4% (2022-2032)
• Click Here To Know More
Market Growth 
Drivers
• Surge in prevalence of mental disorder
• Rise in investment for R&D of psychedelic substances
• Increased social acceptance of psychedelic drugs
• Get Sample Copy: 
https://www.alliedmarketresearch.com/request-sample/1243
3
 
Market Challenges
• Safety uncertainties hinder widespread adoption
• Regulatory barriers limit research and commercialization
• Lingering societal stigma impedes acceptance
• Complexity in clinical research hampers progress
Market Segmentation
• Drug Type: Ketamine, Psilocybin, Others
• Application: Mental Health, Abuse Disorder, Others
• End User: Hospitals, Mental Health Center, Others
Regional Analysis & Key 
Players
• Regional Analysis: North America, Europe, Asia-Pacific, 
LAMEA
• Key Players: Johnson & Johnson, Numinus, Field Trip Health, 
Enveric Biosciences, Havn Life, PharmaTher, Psyched 
Wellness, Ceruvia Lifesciences, Apex Labs, Braxia Scientific
About Us
Allied Market Research (AMR) is a full-service market research and 
business-consulting wing of Allied Analytics LLP based in Portland, 
Oregon. Allied Market Research provides global enterprises as 
well as medium and small businesses with unmatched quality of 
"Market Research Reports" and "Business Intelligence Solutions." 
AMR has a targeted view to provide business insights and 
consulting to assist its clients to make strategic business decisions 
and achieve sustainable growth in their respective market 
domain.
Contact Us
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com